Position in NVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,302,504,897
+$78,645,873 QoQ
Shares Held
8,527,037
-3.9% QoQ
Ownership
0.447%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 52.17892217425584.ToString("F0")%
Shared 0.ToString("F0")%
None 47.821077825744155.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $57,054,147,722 across 20 Drug Manufacturers - General names. NVS ranks #10 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,437,458 | $14,198,910,733 | |
| 2 | JNJ |
Johnson & Johnson
|
44,721,167 | $10,931,642,052 | |
| 3 | ABBV |
AbbVie Inc.
|
38,016,774 | $8,268,268,167 | |
| 4 | MRK |
Merck & Co., Inc.
|
47,632,487 | $5,729,711,852 | |
| 5 | AMGN |
Amgen Inc
|
15,836,058 | $5,571,916,998 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,299,295 | $3,247,222,731 | |
| 7 | PFE |
Pfizer Inc
|
92,685,370 | $2,602,605,180 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,198,554 | $1,770,892,290 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,302,504,897 | 8,527,037 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,223,859,024 | 8,876,906 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $991,150,668 | 7,728,873 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $914,773,637 | 7,559,488 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $786,592,952 | 7,055,911 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $668,437,468 | 6,869,155 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $803,399,972 | 6,984,872 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $789,579,642 | 7,416,679 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $702,103,188 | 7,258,381 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $716,104,780 | 7,092,253 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $710,762,064 | 6,977,833 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $733,154,638 | 7,265,431 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $608,530,872 | 6,614,466 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $588,609,137 | 6,488,196 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $464,459,328 | 6,110,503 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $540,889,377 | 6,398,786 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $286,413,892 | 3,263,976 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $304,714,775 | 3,483,649 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $263,002,760 | 3,215,979 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $270,066,838 | 2,959,961 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $242,771,662 | 2,840,099 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $265,253,207 | 2,808,993 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $221,360,853 | 2,545,548 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $234,835,860 | 2,688,755 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $309,675,106 | 3,755,914 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||